Dr. Richard Gilbert, an internationally renowned diabetes expert and Can-SOLVE CKD project lead, has been named a Fellow of the Canadian Academy of Health Sciences (CAHS). This prestigious distinction, conferred in recognition of leadership, creativity, and commitment to advancing academic health science, is considered one of the highest honours in Canadian health research.
Dr. Gilbert is a Tier 1 Canada Research Chair in Diabetes Complications, Professor of Medicine at the University of Toronto, and Head of the Division of Endocrinology at St. Michael’s Hospital. His pioneering work in advancing our understanding of the way in which long-term complications of diabetes develop has led to the development of new therapies with the potential to prevent, arrest, and ultimately reverse kidney disease and heart failure in diabetes.
He is currently leading a Can-SOLVE CKD research project focused on improving kidney function through first-in-human innovative therapies. The project, which originally focused on determining whether cells derived from bone marrow can prevent the loss of kidney function in individuals with diabetic kidney disease, is currently being re-envisioned with input from patient partners.
The Canadian Academy of Health Sciences brings together Canada’s top-ranked health and biomedical scientists to make a positive impact on the health concerns of Canadians. These Fellows, drawn from a wide range of disciplines, evaluate Canada’s most complex health challenges and recommend strategic, actionable solutions.